Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

ConditionsSystolic Hypertension Pregnancy Related Diastolic Hypertension Cardiac Output, Low Cardiac Output, High

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18-45

SponsorMarshall University

About this trial

The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.

Eligibility criteria

Qualifiers

Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital

English speaking

18-45 years old.

Willing to provide informed consent

Disqualifiers

Non-English speaking patients, patients

<18 years old or >45 years old

Not willing or able to provide consent

Gestational age >15 weeks

Trial design

Treatments tested in this trial

Labetalol
Atenolol
Nifedipine

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Marshall University

Lead sponsor

Source ClinicalTrials.gov